DS9

(2R)-14-fluoro-2-methyl-6,9,10,19-tetrazapentacyclo[14.2.1.02,6.08,18.012,17]nonadeca-1(18),8,12(17),13,15-pentaen-11-one


Toggle HydrogenToggle Labels

Chemical Component Summary

Name(2R)-14-fluoro-2-methyl-6,9,10,19-tetrazapentacyclo[14.2.1.02,6.08,18.012,17]nonadeca-1(18),8,12(17),13,15-pentaen-11-one
FormulaC16 H15 F N4 O
Molecular Weight298.315
TypeNON-POLYMER
Isomeric SMILESC[C@]12CCCN1CC3=NNC(=O)c4cc(cc5c4c3c2[nH]5)F
InChIInChI=1S/C16H15FN4O/c1-16-3-2-4-21(16)7-11-13-12-9(15(22)20-19-11)5-8(17)6-10(12)18-14(13)16/h5-6,18H,2-4,7H2,1H3,(H,20,22)/t16-/m1/s1
InChIKeyDENYZIUJOTUUNY-MRXNPFEDSA-N

Chemical Details

Formal Charge0
Atom Count37
Chiral Atom Count1
Bond Count41
Aromatic Bond Count10

Drug Info: DrugBank

DrugBank IDDB14769 
NamePamiparib
Groups investigational
DescriptionPamiparib is under investigation in clinical trial NCT03933761 (Pamiparib in Fusion Positive, Reversion Negative High Grade Serous Ovarian Cancer or Carcinosarcoma With BRCA1/2 Gene Mutations If Progression on Substrate Poly ADP Ribose Polymerase Inhibitbor (PARPI) or Chemotherapy).
SynonymsPamiparib
Categories
  • Antineoplastic Agents
  • Antineoplastic and Immunomodulating Agents
  • Enzyme Inhibitors
  • Poly (ADP-ribose) polymerase (PARP) inhibitors
  • Poly(ADP-ribose) Polymerase Inhibitors
ATC-CodeL01XK06
CAS number1446261-44-4

Related Resource References

Resource NameReference
Pharos CHEMBL4112930
PubChem 135565554
ChEMBL CHEMBL4112930